Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

The new firm is raising a $150 million fund to back startups around science emerging outside Boston and San Francisco.

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...

Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million ...

Oncolytics Biotech (ONCY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...